Clinical trial
D-Dimer and IPG for Recurrent Thrombosis (DIRECT)
NCT00182247 · Hamilton Health Sciences Corporation, Other · Terminated
Key facts
| NCT number | NCT00182247 |
|---|---|
| Title | D-Dimer and IPG for Recurrent Thrombosis (DIRECT) |
| Official title | D-Dimer and IPG for Recurrent Thrombosis (DIRECT) Study |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Heart and Stroke Foundation of Canada |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis, Pulmonary Embolism |
| Intervention type | Procedure |
| Interventions | venogram |
| Enrollment | 600 |
| Start date | Dec 1, 1998 |
| Completion | Jan 1, 2001 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | Canada, Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: